Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the management of these conditions. Previous studies have...
Saved in:
Main Authors: | Mun Young Cho (Author), Yu Kyung Cho (Author) |
---|---|
Format: | Book |
Published: |
Yong Chan Lee,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potassium-competitive acid blocker-associated gastric mucosal lesions
by: Kimitoshi Kubo, et al.
Published: (2024) -
JP‐1366: A novel and potent potassium‐competitive acid blocker that is effective in the treatment of acid‐related diseases
by: Jin Mo Ku, et al.
Published: (2023) -
Role of Potassium-Competitive Acid Blockers in Helicobacter pylori Eradication
by: Jong Kyu Park
Published: (2017) -
Potassium-competitive Acid Blockers: A New Therapeutic Strategy for Helicobacter pylori Eradication
by: Byeong Yun Ahn, et al.
Published: (2023) -
Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023)